Improvement in epistaxis management: the experience of a dedicated hereditary haemorrhagic telangiectasia clinic.

导出原文传递

翻译打印收藏纠错

作者： Rebecca,Anning ^[1] ; Johnson,Huang ^[1] ; Anne,Ronan ^[2] ; Jillian,de Malmanche ^[3] ; Rebecca,Asher ^[4] ; Tsu-Hui Hubert,Low ^[5]

作者单位： Department of Otolaryngology Head and Neck Surgery, John Hunter Hospital, New Lambton, New South Wales, Australia. ^[1] General Genetics Service, Hunter Genetics, Waratah, New South Wales, Australia. ^[2] School of Medicine and Public Health, The University of Newcastle, Newcastle, New South Wales, Australia. ^[3] Hunter Haematology Unit, Calvary Mater Hospital, Waratah, New South Wales, Australia. ^[4] NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. ^[5] Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia. ^[6] Central Clinical School, University of Sydney, Sydney, New South Wales, Australia. ^[7] Department of Otolaryngology Head and Neck Surgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. ^[8] Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. ^[9]

关键词 Osler-Weber-Rendu arteriovenous malformation autosomal dominant epistaxis hereditary haemorrhagic telangiectasia otolaryngology head & neck surgery